SLC5A2 and type 2 diabetes mellitus: The association of enhanced ketone body production and decreased buffering capacity of blood may also lead to ketoacidosis in patients with type 2 diabetes or even in the absence of hyperglycemia, such as during alcohol abuse or treatment with SGLT2 inhibitors [153, 154].